Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

17934

Supelco

Hydrogen chloride solution

~1.25 M in ethanol, for GC derivatization, LiChropur™

Synonym(s):

Hydrochloric acid in ethanol

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
HCl · CH3CH2OH
CAS Number:
7647-01-0
Molecular Weight:
36.46
Beilstein:
1098214
MDL number:
MFCD00011324
UNSPSC Code:
12352301
eCl@ss:
38050202
PubChem Substance ID:
329751590
NACRES:
NA.22
Pricing and availability is not currently available.

Product Name

Hydrogen chloride – ethanol solution, ~1.25 M HCl, for GC derivatization, LiChropur™

grade

for GC derivatization

Quality Level

100

form

liquid

quality

LiChropur™

reaction suitability

reagent type: derivatization reagent
reaction type: Alkylations

concentration

~1.25 M HCl

technique(s)

gas chromatography (GC): suitable

density

0.825 g/mL at 20 °C

storage temp.

2-8°C

SMILES string

Cl

InChI

1S/ClH/h1H

InChI key

VEXZGXHMUGYJMC-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Legal Information

LiChropur is a trademark of Merck KGaA, Darmstadt, Germany

Pictograms

FlameCorrosion
GHS02,GHS05

Signal Word

Danger

Hazard Statements

H225,H290,H319

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 2 - Met. Corr. 1

Storage Class Code

3 - Flammable liquids

WGK

WGK 1

Flash Point(F)

60.8 °F

Flash Point(C)

16 °C

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCM4175
BCCD9205
BCBV9173
BCBQ2377V
SHBD4850V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A reversible inactivation of insulin.
F H Carr et al.
The Biochemical journal, 23(5), 1010-1021 (1929-01-01)
Jay G Hosking et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(4), 1005-1015 (2014-10-21)
Successful decision making often requires weighing a given option's costs against its associated benefits, an ability that appears perturbed in virtually every severe mental illness. Animal models of such cost/benefit decision making overwhelmingly implicate mesolimbic dopamine in our willingness to
Sandra Donkervoort et al.
Human mutation, 36(1), 48-56 (2014-09-11)
Collagen 6-related dystrophies and myopathies (COL6-RD) are a group of disorders that form a wide phenotypic spectrum, ranging from severe Ullrich congenital muscular dystrophy, intermediate phenotypes, to the milder Bethlem myopathy. Both inter- and intrafamilial variable expressivity are commonly observed.
Ann Brinkmalm et al.
Molecular neurodegeneration, 9, 53-53 (2014-11-25)
Synaptic degeneration is an early pathogenic event in Alzheimer's disease, associated with cognitive impairment and disease progression. Cerebrospinal fluid biomarkers reflecting synaptic integrity would be highly valuable tools to monitor synaptic degeneration directly in patients. We previously showed that synaptic
Robert Goldstein et al.
European journal of nuclear medicine and molecular imaging, 42(2), 288-301 (2014-11-14)
Human epidermal growth factor receptor-2 (HER2) overexpression is a predictor of response to anti-HER2 therapy in breast and gastric cancer. Currently, HER2 status is assessed by tumour biopsy, but this may not be representative of the larger tumour mass or
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service